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INTRODUCTION
Acute respiratory distress syndrome (ARDS) is a signifi-
cant cause of admission and death in intensive care units
(ICUs), despite recent development in ventilatory strategies
and supportive critical care (1). Reported ARDS mortality
rates vary significantly (2-10); this variability is thought to
be partly due to the heterogeneity of disease severity as well
as the vague definition of ARDS (4) and variable therapeu-
tic strategies.
To compare mortality rates between different institutions,
the effects of newer treatment methods, and to identify high
mortality groups, a scoring system that can objectively mea-
sure the severity-of-illness of ARDS patients would be help-
ful. Over the past 20 yr, there have been numerous efforts to
develop models that provide severity-of-illness measures to
objectively describe ICU populations (11, 12), and ICU risk-
prediction models were constructed for heterogeneous patients
in ICUs. Severity scoring systems that can be applied to patients
with ARDS can be divided into two types. One type aims
to estimate general health condition of critically ill patients,
and the other focuses on the severity of lung injury.
Among the severity scoring systems that have been pro-
posed for critically ill patients, the acute physiology and
chronic health evaluation (APACHE) and the simplified
acute physiology score (SAPS) systems are frequently used.
The performances of these systems in ICUs have been report-
ed as satisfactory (3, 7, 13). 
APACHE II and SAPS II were originally developed for
predicting the prognosis of critically ill patients. Both of
these scoring systems focus on evaluating the general health
of the patients. By contrast, the lung injury score (LIS) (14)
and the Gas exchange, Organ failure, Cause, Associated dis-
ease (GOCA) score (15) were developed specifically for pati-
ents with ARDS to define or stratify the disease (but not to
predict prognosis). LIS mainly focuses on the severity of lung
injury. 
The scoring systems for general critically ill patients may
not accurately predict the prognosis in highly specialized
patients such as ARDS (16, 17). Furthermore, the scoring
systems that focus on mainly lung condition also can not
predict the prognosis of ARDS because the degree of hypox-
ia was not correlated with the mortality of those patients (6-
8). Theoretically, GOCA can be superior to APACHE II or
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The Clinical Efficacy of GOCA Scoring System in Patients with Acute
Respiratory Distress Syndrome
To explore the following hypotheses: 1) Gas exchange, Organ failure, Cause, Associ-
ated disease (GOCA) score, which reflects both general health and the severity of
lung injury, would be a better mortality predictor of acute respiratory distress syn-
drome (ARDS) than acute physiology and chronic health evaluation (APACHE II)
or simplified acute physiology score (SAPS II), which are not specific to lung injury,
and lung injury score (LIS) that focuses on the lung injury; 2) the performance of
APACHE II and SAPS II will be improved when reinforced by LIS, we retrospec-
tively analyzed ARDS patients (N=158) admitted to a medical intensive care unit
for five years. The overall mortality of the ARDS patients was 53.2%. Calibrations
for all models were good. The area under the curve of (AUC) of LIS (0.622) was
significantly less than those of APACHE II (0.743) and SAPS II (0.753). The AUC
of GOCA (0.703) was not better than those of APACHE II and SAPS II. The AUCs
of APACHE II and SAPS II tended to further increase when reinforced by LIS. In
conclusion, GOCA was not superior to APACHE II or SAPS II. The performance
of the APACHE II or SAPS II tended to improve when combining a general scor-
ing system with a scoring system that focused on the severity of lung injury.
Key Words : Respiratory Distress Syndrome, Adult; APACHE; SAPS II; GOCA; LIS; Severity Scoring System;
Mortality; Patients
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Accepted : 11 October 2007SAPS II for predicting the prognosis of patients with ARDS
because it considers the severity of lung injury as well as gen-
eral health condition. The mortality predictive performance of
the GOCA system for ARDS patients has not been adequate-
ly addressed, and there are few reports that have evaluated
the overall performances of LIS, APACHE II, and SAPS II
on ARDS patients.
We formed two hypotheses in this study. One is that nei-
ther the severity scoring systems that reflect general condi-
tion nor those reflect severity of lung injury can accurately
predict prognosis of patients with ARDS when used alone.
Therefore, GOCA, which reflects general health condition
in addition to the severity of lung injury, can be a better mor-
tality predictor than APACHE II, SAPS II and LIS. The
other is that the performance of APACHE II and SAPS II
will be improved when they are reinforced by a scoring sys-
tem that focuses on the severity of lung injury (e.g., LIS). To
address these hypotheses, we compared the performances of
the above severity scoring systems - separately and combined-
for predicting mortality of patients with ARDS.
MATERIALS AND METHODS
Subjects
The study was performed in a 28-bed medical intensive care
unit (MICU) at the Asan Medical Center, a university-affili-
ated tertiary referral center in Seoul, Korea. Data from 158
patients with ARDS admitted to the MICU from 1 January
1997 to 31 December 2001 were retrospectively evaluated.
To identify eligible patients, we reviewed the medical
records of 1,787 patients treated with mechanical ventila-
tion during the study period. The diagnosis of ARDS was
made by a physician and a radiologist according to the Amer-
ican-European Consensus Conference criteria (4). Patients
under 17 yr old and those who had a history of chronic obstruc-
tive pulmonary disease, interstitial lung disease, lung cancer
or tuberculous destroyed lung were excluded from the anal-
ysis. There were 369 patients who showed PaO2/FiO2 ratios
less than 200 mmHg without any exclusion criteria. Of these,
158 patients showed bilateral chest radiograph infiltrates
compatible with ARDS and no evidence of left atrial hyper-
tension (4) as determined by the Swan-Ganz catheter method
or echocardiography. Survival status was evaluated at hospi-
tal discharge.
Mortality prediction models
APACHE II (11), SAPS II (12), GOCA (15), and LIS (14)
were calculated for all ARDS patients. Two models were
made for each scoring system via logistic regression. One
model used severity scores only (model 1), while the other
model included patient location before MICU admission in
addition to severity scores (model 2). We also evaluated the
performance of combined scoring systems-APACHE II and
LIS, SAPS II, and LIS. 
The mean LIS was 2.80±0.47. LIS was higher than 2.5
in most of the patients (82%). We treated LIS as a continu-
ous variable.
Statistical methods
To compare categorical data, chi-square and Fisher’s exact
tests were used. Student t-tests were used for continuous data.
The ability to provide risk estimations corresponding to actu-
al mortality rates (calibration) and the ability to correctly
classify survivors and non-survivors according to the estimat-
ed probability of death (discrimination) were measured for
each scoring system. 
Calibrations of each model were compared by Hosmer-
Lemeshow’s goodness-of-fit test. Hosmer-Lemeshow’s C and
H chi-square tests, representing two different strategies for
classification of estimated probabilities of death, were used
to assess the goodness of fit for each model. For the evalua-
tion of calibration, model 2 was used. The areas under the
curves of the receiver operating characteristics (AUCs) and 2
×2 classification tables at decision criteria of 50% and 55%
were used for the evaluation of discrimination of the scoring
systems. 
The difference of severity scores according to patient loca-
tion before MICU admission was determined by one-way
ANOVA. All statistical tests were two-sided, and we set a
significance level of p<0.05.
RESULTS
Demographic features and clinical characteristics of
patients
Demographics, initial physiologic and laboratory data, and
severity scores of patients are shown in Table 1. Also present-
ed are the results from statistical comparisons between sur-
vivors and non-survivors. Eighty-four (53.2%) patients died
in hospital and 74 patients survived. Five patients died on
the medical floor after discharge from the ICU. The ICU mor-
tality was 50%. 
Thirty-five patients had ARDS associated with extrapul-
monary diseases and 123 patients had pulmonary causes. Pul-
monary causes of ARDS were pneumonia (n=84), aspiration
(n=22), near drowning (n=5), miliary tuberculosis (n=6),
acute interstitial pneumonitis (n=5), and inhalation injury
(n=1). Extrapulmmonary causes were sepsis (n=23), trauma
(n=5), pancreatitis (n=2), massive transfusion (n=1), and
drug and others (n=4). The most common predisposing fac-
tors for ARDS were pneumonia and nonpulmonary sepsis.
There was no difference in mortality between pulmonary
384 Y. Jegal, S.-I. Lee, K.-H. Lee, et al.and extrapulmonary ARDS (p=0.183). There was no differ-
ence in mortality according to the year of admission (p=
0.288), either. We used pressure-controlled ventilation, low
tidal volume, prone position, and inhalation of nitric oxide
for ARDS. There were no changes in treatment strategies
for ARDS in our institution during the study period.
Non-survivors were older than survivors and also showed
significantly higher positive end expiratory pressure (PEEP),
lower pH, lower bicarbonate, lower hematocrit, higher blood
urea nitrogen, higher glucose, lower cholesterol, higher biliru-
bin, and lower potassium levels than survivors. The means of
all severity scores were significantly higher in non-survivors
than survivors. However, gender and PaO2/FiO2 ratios were
not significantly different between the two groups (Table 1).
Mortality rates were significantly different according to the
patient location before MICU admission (p<0.001). Patients
who had been transferred from other hospitals showed bet-
ter survival than those transferred from the medical floor,
emergency room, or other ICUs, with patients who had been
transferred from the medical floor showing the worst prog-
nosis. Except for LIS, all severity scores showed significant
differences according to the patient location before MICU
admission (SAPS II, p=0.011; GOCA, p<0.001; APACHE
II, p=0.010; LIS, p=0.890). In post-hoc comparisons, SAPS
II values for patients from the medical floor were higher than
those from other hospitals; GOCA scores for patients from
the medical floor were higher than those from other hospi-
tals, other ICUs, and the emergency room; and APACHE II
scores of patients from the medical floor were higher than
those from other ICUs.
Calibration (goodness-of-fit) of scoring systems
Goodness-of-fit testing was performed using Hosmer-
Lemeshow’s H and C chi-square tests for model 2 (Table 2).
Calibration curves are shown in Fig. 1. The overall calibra-
tions of all systems were good. 
Discrimination of scoring systems: Receiver operating
characteristic (ROC) curves
ROC curves for the models are shown in Fig. 2. The AUCs
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All patients 158 Survivors 74 Non-survivors 84 p value
Age 57.0±15.7 54.2±15.7 59.4±15.3 0.035
Sex (male:female) 119:39 55:19 64:20 0.786
Number of organ failures 0.8±0.9 0.4±0.7 1.1±1.0 <0.001
Urine output (mL/day) 2,393±1,583 2,651±1,506 2,165±1,623 0.054
PEEP (mmHg) 7.5±3.2 7.0±3.2 8.1±3.0 0.026
PaO2/FiO2 ratio 114.0±38.6 113.3±38.7 114.6±38.8 0.840
pH 7.39±0.11 7.41±0.09 7.36±0.13 0.016
PaCO2 (mmHg) 37.9±11.1 37.5±10.7 38.3±11.5 0.644
Bicarbonate (mM/L) 23.1±8.2 24.5±10.4 22.0±5.5 0.046
WBC (/μ L) 15,100±21,900 13,700±8,900 16,200±28,900 0.482
Hematocrit 29.6±6.2 31.4±5.9 28.1±6.1 0.001
Platelet (/μ L) 175,000±163,000 174,000±122,000 175,000±193,000 0.971
BUN (mg/dL) 32.9±29.5 26.8±22.8 38.3±33.6 0.012
Creatinine (mg/dL) 1.67±1.65 1.48±1.69 1.82±1.60 0.197
Glucose (mg/dL)  175.8±85.1 160.6±78.4 189.1±89.0 0.037
Albumin (g/dL) 2.20±0.56 2.27±0.58 2.15±0.53 0.194
Cholesterol (mg/dL) 97.1±41.6 104.9±46.4 90.4±36.0 0.035
Bilirubin (mg/dL) 3.70±6.37 2.67±4.23 4.61±7.69 0.049
Sodium (mM/L) 134.6±7.3 135.5±6.7 133.8±7.8 0.136
Potassium (mM/L) 3.85±0.78 3.71±0.74 3.97±0.80 0.041
Prothrombin time (INR) 1.558±0.866 1.431±0.728 1.669±0.962 0.081
Glasgow coma scale 14.1±1.6 14.6±1.2 14.3±1.8 0.219
APACHE II 17.63±5.43 15.22±4.71 19.75±5.15 <0.001
SAPS II 44.35±13.02 38.27±10.38 49.71±12.80 <0.001
GOCA 4.95±1.43 4.41±1.17 5.43±1.47 <0.001
LIS 2.796±2.750 2.696±0.427 2.884±0.483 0.011
Patient location before MICU admission <0.001
Medical floor 49 11 38
Emergency room 25 11 14
Other ICUs 27 15 12
Other hospitals 57 37 20
Table 1. Demographic characteristics and severity scoring systems of patients
PEEP, positive end expiratory pressure; WBC, white blood cell count; BUN, blood urea nitrogen; MICU, medical intensive care unit.of model 1 were 0.743 for APACHE II, 0.753 for SAPS II,
0.703 for GOCA, and 0.622 for LIS (Table 3). The discrimi-
nation power of LIS was significantly inferior to APACHE
II and SAPS II. When the model included age, sex, patient
location before MICU admission, and cholesterol in addition
to test scores, only patient location before MICU admission
increased the AUC. The AUCs of APACHE II and SAPS II
tended to further increase when the mortality prediction mod-
els were reinforced by LIS, with values of 0.800 and 0.810,
respectively (Table 3).
Discrimination of scoring systems: 2× ×2 tables according
to decision criteria
Table 4 shows the 2×2 classification matrices at decision
criteria of 50% and 55%. The decision criteria were chosen
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Fig. 1. Calibration curves for APAHCE II, SAPS II, GOCA, and LIS.
Unmarked lines represent the line of perfect correspondence
between actual and predicted risk of death; marked lines repre-
sent the calibration curves. The models used for calibration curves
were made using patient location before MICU admission in addi-
tion to severity scores.
Fig. 2. ROC curves of severity scores. The discriminative power of LIS was inferior to both APACHE II and SAPS II (A). When the models
incorporated patient location before MICU admission in addition to severity scores, all the areas under the curves were increased (B).
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*H denotes that the tables were collapsed on fixed values of the esti-
mated probabilities; 
� C denotes that the tables were collapsed on deciles
of the estimated probabilities.
The models used in estimating calibrations were made using patient
location before MICU admission in addition to severity scores.
APACHE II SAPS II GOCA LIS
H chi-square* 7.3269 6.5038 8.2342 7.0496
(p value) (0.5018) (0.4823) (0.3124) (0.4237)
C chi-square
� 9.6480 10.5349 6.1468 9.8000
(p value) (0.2094) (0.2295) (0.6308) (0.2793)
Table 2. Hosmer-Lemeshow’s H and C chi-square tests for scor-
ing systems
*Model 1 was made using severity scores only; 
� Model 2 was made
using patient location before MICU admission in addition to severity
scores; 
� Model 2+LIS is model 2 reinforced by LIS.
Scoring
system
The area under the ROC curves (95% confidence interval)
Model 1* Model 2
� Model 2+LIS
�
APACHE II 0.743 0.786 0.800
(0.667-0.820) (0.716-0.856) (0.732-0.868)
SAPS II 0.753 0.791 0.810
(0.678-0.827) (0.720-0.861) (0.744-0.876)
GOCA 0.703 0.759 -
(0.621-0.784) (0.683-0.835)
LIS 0.622 --
(0.534-0.710)
Table 3. Areas under the receiver operating characteristic (ROC)
curves of each severity scoring system
APACHE II
SAPS II
GOCAarbitrarily because actual mortality was 53.2%. Overall cor-
rect classifications of scoring systems were approximately
70% and were similar among systems. 
DISCUSSION
To our knowledge, this is the first report that evaluates the
performance of GOCA for patients with ARDS. Although
this study failed to reveal the superiority of GOCA to other
severity scoring systems, it suggested that a scoring system
that combined general health condition and lung condition
can well predict the mortality of patients with ARDS.
The general severity scoring systems, such as APACHE II
and SAPS II, showed better performance in predicting mor-
tality of patients with ARDS than LIS, which focuses only
on the severity of respiratory failure. APACHE II and SAPS
II scores have been previously reported to be independent
predictors of hospital mortality in patients with ARDS (3,
7, 13, 18). However, these studies evaluated the significance
of severity scores using only Student t-tests or logistic regres-
sion. Although these tests have shown excellent performances
on overall critically ill patients, there are only a few reports
that have validated the overall performance of these severity
scoring systems in ARDS patients (12, 19). 
The discriminative powers of APACHE II and SAPS II
were considered excellent in previous reports addressing over-
all critically ill patients (12, 19, 20). The discriminative pow-
ers of these scores were inferior in this study compared to
previous studies, possibly because these scoring systems were
originally developed for overall critically ill patients, not
specifically for patients with ARDS.
We found that LIS was inferior to APACHE II and SAPS
II in predicting ARDS mortality. LIS is obtained by divid-
ing the aggregate sum by the number of components that
are used. There are four components; the extent of alveolar
consolidation (0-4), the degree of hypoxia (0-4), the degree
of respiratory system compliance (0-4), and the degree of
PEEP (0-4). The PaO2/FiO2 ratio was not different between
survivors and non-survivors, and this lack of relationship
between the degree of hypoxia and mortality might have
contributed to the shortage of discriminative power of LIS.
The relationship between hypoxia and mortality of ARDS
patients remains controversial, as has been reported in previ-
ous studies (6-8). 
Previous studies have also reported that LIS was not suit-
able for predicting ARDS patient outcome (6-8) and the dis-
criminative power of LIS for overall survival was inferior to
SAPS or APACHE II scores (6, 21). There are two possible
explanations for the inferiority of the LIS. First, the develop-
ment of many strategies that support respiratory ability have
led to general health condition, rather than lung function,
being the major prognostic factor even in patients with ARDS.
Second, LIS was originally developed to define ARDS, not
to predict prognosis (14). 
The GOCA stratification system was proposed by the Amer-
ican-European Consensus Conference on ARDS to assess the
severity of acute lung injury and the associated clinical fea-
tures (15). GOCA considers not only the severity of lung
injury but also a few general conditions such as the number
of organ failure and associated diseases. The GOCA score is
the sum of four variables; the severity of gas exchange (0-3),
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APACHE II predicted
Dead Alive Total
Decision
criterion
SAPS II predicted
Dead Alive Total
GOCA predicted
Dead Alive Total
50% observed
Dead 61 23 84 61 23 84 53 31 84
Alive 24 50 74 18 56 74 15 59 74
Total 85 73 158 79 79 158 68 90 158
Sensitivity (%) 72.6 72.6 63.1
Specificity (%) 67.6 75.7 79.7
Positive predicted value (%) 71.8 77.2 77.9
Negative predicted value (%) 68.5 70.9 65.6
Correct classification (%) 70.3 74.1 70.9
55% observed
Dead 57 27 84 58 26 84 53 31 84
Alive 14 60 74 17 57 74 15 59 74
Total 71 87 158 75 83 158 68 90 158
Sensitivity (%) 67.9 69.0 63.1
Specificity (%) 81.0 77.0 79.7
Positive predicted value (%) 80.3 77.3 77.9
Negative predicted value (%) 69.0 68.7 65.6
Correct classification (%) 74.1 72.8 70.9
Table 4. Classification tables (2×2 matrices) for scoring systems with decision criteria at 50% and 55%
The models used in this table were made using patient location before MICU admission in addition to severity scores.the number of organ failure (0-3), the cause of lung injury
(0: lung only, 1: direct lung injury, and 2: indirect lung injury)
and associated diseases (0: no associated disease that will cause
death within 5 yr, 1: coexisting diseases that will cause death
within 5 yr but not within 6 months, and 2: coexisting dis-
eases that will cause death within 6 months).
Although the GOCA score is not designed to predict out-
come, we have hypothesized that GOCA can be better than
the other scoring systems in predicting prognosis of ARDS
patients because it considers the general health condition of
patients in addition to the severity of lung injury. Our results
did not, however, show any predictive advantage of the GOCA
system. This may be because the scoring for associated dis-
eases in GOCA is dependent on the subjective judgment of
the attending physician and the differentiation of primary
disease is too crude. On the other hand, GOCA may prove
to be more convenient to use than APACHE II or SAPS II
because it requires fewer variables but provides the same pre-
dictive power. 
Monchi et al. proposed an ARDS severity scoring system
showing excellent discrimination and calibration that includ-
ed variables representing general patient condition and oxy-
genation (3). Reiter et al. also reported that risk adjustments
were improved in critically ill trauma patients by combin-
ing two different scoring systems (22). In our patients, AUCs
tended to increase when APACHE II and SAPS II were rein-
forced by LIS. The significant difference of the PEEP level
between non-survivors and survivors can contribute to the
AUC increase in the combined model although compliance
(31.1±14.6 vs. 33.5±14.3, p=0.353) and PaO2/FiO2 ratio
were not different from survivors and non-survivors. The
improved discrimination implies that excellent mortality
prediction models for ARDS can be developed by consider-
ing both general health condition and severity of lung injury
if the variables that evaluate general health are more refined
than those of GOCA.
The overall hospital mortality in this study was 53.2%,
which was similar to the rates reported in several other stud-
ies (6, 8, 9, 18). Hospital mortality in this study was highly
affected by patient location before MICU admission. The
prognosis of patients who transferred from other hospitals
was better than in the other three groups, while patients
transferred from the medical floor showed the worst prog-
nosis. Differences in mortality among these groups might
be due to differences in the severity of illness. Patients who
could be transferred from other hospitals probably represent-
ed less severe cases than those from the medical floor. Many
patients from the medical floor were transferred after car-
diopulmonary resuscitation and, therefore, must have been
severely ill. 
Because the severity scores of patients from the medical
floor were significantly higher than those of the other groups,
the use of the patient location before MICU admission as an
independent variable might be unreasonable. However, mul-
tivariate logistic regression analysis for GOCA, APACHE
II, SAPS II, LIS, and prior location before MICU showed
that the patient location before MICU admission was an
important independent mortality predictor (p=0.014). Fur-
thermore, model 1, which did not include the patient loca-
tion before MICU admission showed a similar result as in
model 2; the discriminative power of LIS was inferior to those
of APACHE II and SAPS II and that of GOCA was similar
to those of APACHE II and SAPS II. 
The calibration of a model refers to how well predicted
outcomes compare to observed outcomes over the full range
of risk levels (23). In general, Hosmer-Lemeshow statistics
lower than 15 and p values of 0.2 to 0.8 are considered good
(24). With this guideline, the severity scoring systems in this
study calibrated well in ARDS patients.
There were a few limitations in this study. The first is that
only patients admitted to the MICU were included, and
therefore, the conclusion might have been different when
patients in surgical ICUs were included. Secondly, the num-
ber of patients was relatively small compared to studies on
overall critically ill patients. Because of this relatively small
sample size, we could not divide our patients into develop-
mental and validation data sets. Nevertheless, our series was
still larger than several other ARDS-specific studies (6-8). 
In conclusion, GOCA failed to show the superiority to
APACHE II or SAPS II. The performance of APACHE II
or SAPS II tended to improve when combining a general
scoring system with a scoring system that focused on the
severity of lung injury. Therefore, a new severity scoring sys-
tem should consider all of these variables to possess excellent
mortality predictive performance for ARDS patients.
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